Drug Database · Clinicians

Oxytocin

Brands (50) Ashxytin, Lavoxin, Syntomax…Show all

Oxytocic US FDA class
Posterior pituitary lobe hormones (oxytocin and analogues); Posterior pituitary hormones; and others PH FDA category

Rx · Prescription drug55 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID c7fd585a-99b7-4309-b003-a6cbef05372c, version date January 12, 2026 (Oxytocin · Fresenius Kabi USA, LLC). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE IMPORTANT NOTICE: Oxytocin Injection, USP (synthetic) is indicated for the medical rather than the elective induction of labor.
  • induction of labor in patients with a medical indication for the initiation of labor, such as Rh problems, maternal diabetes, pre-eclampsia at or near term, when delivery is in the best interest of mother and fetus or…
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE IMPORTANT NOTICE: Oxytocin Injection, USP (synthetic) is indicated for the medical rather than the elective induction of labor. Available data and information are inadequate to define the benefits to risks considerations in the use of the drug product for elective induction. Elective induction of labor is defined as the initiation of labor for convenience in an individual with a term pregnancy who is free of medical indications.

Antepartum Oxytocin injection (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons. It is indicated for (1) induction of labor in patients with a medical indication for the initiation of labor, such as Rh problems, maternal diabetes, pre-eclampsia at or near term, when delivery is in the best interest of mother and fetus or when membranes are prematurely ruptured and delivery is indicated; (2) stimulation or reinforcement of labor, as in selected cases of uterine inertia; (3) adjunctive therapy in the management of incomplete or inevitable abortion.

In the first trimester, curettage is generally considered primary therapy. In second trimester abortion, oxytocin infusion will often be successful in emptying the uterus. Other means of therapy, however, may be required in such cases. Postpartum Oxytocin injection (synthetic) is indicated to produce uterine contractions during the third stage of labor and to control postpartum bleeding or hemorrhage.

Antepartum Oxytocin injection (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons. It is indicated for (1) induction of labor in patients with a medical indication for the initiation of labor, such as Rh problems, maternal diabetes, pre-eclampsia at or near term, when delivery is in the best interest of mother and fetus or when membranes are prematurely ruptured and delivery is indicated; (2) stimulation or reinforcement of labor, as in selected cases of uterine inertia; (3) adjunctive therapy in the management of incomplete or inevitable abortion.

In the first trimester, curettage is generally considered primary therapy. In second trimester abortion, oxytocin infusion will often be successful in emptying the uterus. Other means of therapy, however, may be required in such cases.

Postpartum Oxytocin injection (synthetic) is indicated to produce uterine contractions during the third stage of labor and to control postpartum bleeding or hemorrhage.

Contraindications

CONTRAINDICATIONS Oxytocin injection (synthetic) is contraindicated in any of the following conditions:

  • Significant cephalopelvic disproportion;
  • Unfavorable fetal positions or presentations which are undeliverable without conversion prior to delivery, i.e., transverse lies;
  • In obstetrical emergencies where the benefit-to-risk ratio for either the fetus or the mother favors surgical intervention;
  • In cases of fetal distress where delivery is not imminent;
  • Prolonged use in uterine inertia or severe toxemia;
  • Hypertonic uterine patterns;
  • Patients with hypersensitivity to the drug;
  • Induction or augmentation of labor in those cases where vaginal delivery is contraindicated, such as cord presentation or prolapse, total placenta previa, and vasa previa.
US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION Dosage of oxytocin is determined by uterine response. The following dosage information is based upon the various regimens and indications in general use. Induction or Stimulation of Labor Intravenous infusion (drip method) is the only acceptable method of administration for the induction or stimulation of labor.

Accurate control of the rate of infusion flow is essential. An infusion pump or other such device and frequent monitoring of strength of contractions and fetal heart rate are necessary for the safe administration of oxytocin for the induction or stimulation of labor. If uterine contractions become too powerful, the infusion can be abruptly stopped, and oxytocic stimulation of the uterine musculature will soon wane.

An intravenous infusion of a non-oxytocin containing solution should be started. Physiologic electrolyte solutions should be used except under unusual circumstances. To prepare the usual solution for intravenous infusion–one mL (10 units) is combined aseptically with 1,000 mL of a non-hydrating diluent. The combined solution, rotated in the infusion bottle to insure thorough mixing, contains 10 mU/mL.

Add the container with dilute oxytocic solution to the system through the use of a constant infusion pump or other such device to control accurately the rate of infusion. The initial dose should be no more than 1 to 2 mU/min. The dose may be gradually increased in increments of no more than 1 to 2 mU/min., until a contraction pattern has been established which is similar to normal labor.

The fetal heart rate, resting uterine tone, and the frequency, duration, and force of contractions should be monitored. The oxytocin infusion should be discontinued immediately in the event of uterine hyperactivity or fetal distress. Oxygen should be administered to the mother. The mother and fetus must be evaluated by the responsible physician.

Control of Postpartum Uterine Bleeding Intravenous Infusion (Drip Method )—To control postpartum bleeding, 10 to 40 units of oxytocin may be added to 1,000 mL of a nonhydrating diluent and run at a rate necessary to control uterine atony. Intramuscular Administration —1 mL (10 units) of oxytocin can be given after delivery of the placenta.

Treatment of Incomplete or Inevitable Abortion Intravenous infusion with physiologic saline solution, 500 mL, or 5% dextrose in physiologic saline solution to which 10 units of oxytocin have been added should be infused at a rate of 20 to 40 drops/minute. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Induction or Stimulation of Labor Intravenous infusion (drip method) is the only acceptable method of administration for the induction or stimulation of labor. Accurate control of the rate of infusion flow is essential. An infusion pump or other such device and frequent monitoring of strength of contractions and fetal heart rate are necessary for the safe administration of oxytocin for the induction or stimulation of labor.

If uterine contractions become too powerful, the infusion can be abruptly stopped, and oxytocic stimulation of the uterine musculature will soon wane. An intravenous infusion of a non-oxytocin containing solution should be started. Physiologic electrolyte solutions should be used except under unusual circumstances. To prepare the usual solution for intravenous infusion–one mL (10 units) is combined aseptically with 1,000 mL of a non-hydrating diluent.

The combined solution, rotated in the infusion bottle to insure thorough mixing, contains 10 mU/mL. Add the container with dilute oxytocic solution to the system through the use of a constant infusion pump or other such device to control accurately the rate of infusion. The initial dose should be no more than 1 to 2 mU/min.

The dose may be gradually increased in increments of no more than 1 to 2 mU/min., until a contraction pattern has been established which is similar to normal labor. The fetal heart rate, resting uterine tone, and the frequency, duration, and force of contractions should be monitored. The oxytocin infusion should be discontinued immediately in the event of uterine hyperactivity or fetal distress.

Oxygen should be administered to the mother. The mother and fetus must be evaluated by the responsible physician.

Control of Postpartum Uterine Bleeding Intravenous Infusion (Drip Method )—To control postpartum bleeding, 10 to 40 units of oxytocin may be added to 1,000 mL of a nonhydrating diluent and run at a rate necessary to control uterine atony. Intramuscular Administration —1 mL (10 units) of oxytocin can be given after delivery of the placenta.

Treatment of Incomplete or Inevitable Abortion Intravenous infusion with physiologic saline solution, 500 mL, or 5% dextrose in physiologic saline solution to which 10 units of oxytocin have been added should be infused at a rate of 20 to 40 drops/minute. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Solution for injection: 5 IU/mL, 10 IU per mL, 10 IU/mL
  • Concentrate for solution for injection: 5 IU per mL

Registered products in the Philippines

55 products registered with the Food and Drug Administration (FDA) Philippines list Oxytocin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products55
Philippine FDA-registered products for Oxytocin
Package insert
AcutocinOxytocin
10 IU/mL Solution for Injection (I.M./I.V./S.C.)1 mL USP Type I clear glass ampoule with snap of brown band in 5 PVC trays x 10's (Box of 50's)
Rx
Aculife Healthcare Private LimitedIndia
Blue Global (FZE)
DRP-12831
Oct 13, 2027
AeoxOxytocin
10 IU / mL Solution for Injection (I.M/I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Umedica Laboratories Pvt. Ltd.India
Dynasty PharmaceuticalsImporter: Suhitas Pharmaceuticals Inc.
DRP-4985-08
Dec 11, 2028
AmbitocynOxytocin
10 IU/mL Solution for Injection1 mL USP Type I Amber glass ampoule (Box of 5's)
Rx
Sanjivani Paranteral Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Unicare Healthsciences Pvt. Ltd.
DRP-6317-02
Jan 12, 2028
AmbitoxOxytocin
10 I.U./mL Solution for Injection (IV)Clear and Colorless Glass Ampoule x 1 mL in a Blister Tray (Box of 10’s)
Rx
CSPC Ouyi Pharmaceutical Co. Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DR-XY40469
Jan 2, 2030
AmbtocynOxytocin
10 I.U. / mL Solution for Injection (I.M./I.V.)1 mL Type I Clear and Colorless Glass Ampoule in Clear PVC Tray (Box of 10's)
Rx
Ma'anshan BBCA Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-8474
Mar 18, 2031
ArkocinOxytocin
10 IU/mL Solution for Injection (I.M./I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
Ark Gen Pharma Corp.Importer: Suhitas Pharmaceuticals Inc.
DRP-4985-04
Dec 11, 2028
AshxytinOxytocin
10 IU/mL Solution for Injection1 mL USP Type I Amber glass ampoule (Box of 5's)
Rx
Sanjivani Paranteral Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Unicare Healthsciences Pvt. Ltd.
DRP-6317-07
Jan 12, 2028
AshxytinOxytocin
10 IU/mL Solution for Injection (I.M./I.V.)1 mL USP Type I Amber Glass Ampoule (Box of 5's)
Rx
Apoorv InternationalIndia
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-6317-06
Jan 12, 2028
CleartocinOxytocin
10 IU/mL Solution for Injection1 mL USP Type I Amber glass ampoule (Box of 5's)
Rx
Sanjivani Paranteral Ltd.India
CV Clearvue Pharma, Inc.Importer: Ambica International CorporationTrader: Unicare Healthsciences Pvt. Ltd.
DRP-6317-04
Jan 12, 2028
DynoxOxytocin
10 I.U./ml Solution for Injection (I.M./I.V.)1 ml Type I Clear and Colorless Glass Ampoule in Clear PVC Tray (Box of 10’s)
Rx
Ma'anshan BBCA Pharmaceutical Co., Ltd.China
Dynasty PharmaceuticalsImporter: Amb Hk Enterprises Inc.
DRP-8474-03
Apr 23, 2031
ErgitocinOxytocin
10 IU/mL Solution for Injection (IM/IV)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Harmann Pharmaceutical Laboratories (Pvt) Ltd.Pakistan
Medlane Pharma Inc.Importer: Raquel-Abbas Pharmaceuticals & General Merchandise
DRP-9991-01
May 13, 2031
EvatocinOxytocin
10 IU/mL Solution for Injection (IM/IV)USP Type I Clear Glass Ampoule x 1mL (Box of 10's)
Rx
Neon Laboratories LimitedIndia
Elin Pharmaceuticals, Inc.
DR-XY25834
Sep 19, 2031
EvexyOxytocin
10 IU/mL Solution for Injection (IM/IV Infusion)Type I Hydrolytic Resistant Glass Colourless Borosilicate Glass Ampoule X 1 mL (Net Content) (Box of 10's)
Rx
HBM Pharma S.R.O.Slovak Republic
Tamiga Pharmaceuticals SupplyImporter: Ambica International CorporationTrader: JSC Grindeks
DRP-8748
Feb 21, 2030
ExatoxynOxytocin
10 IU/mL Solution for Injection (IM/IV)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Harmann Pharmaceutical Laboratories (Pvt) Ltd.Pakistan
Exa Life Care Pharma Inc.Importer: Raquel-Abbas Pharmaceuticals & General Merchandise
DRP-9991-02
May 13, 2031
ExertaOxytocin
10 IU/mL Solution for Injection (I.M/I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
The Cathay Drug Co., Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-4985-03
Dec 11, 2028
FetusinOxytocin
10 IU/mL Solution for Injection (I.M./I.V.)USP Type I clear glass ampoule x 1 mL (net content). Box of 10's.
Rx
Sterile-Gene Life Sciences (P) Ltd.India
Vamsler Phils. Inc.Importer: Euro-Health Care Exponents, Inc.
DRP-12552
Sep 1, 2027
GentocinOxytocin
10 IU /mL Solution for Injection (IM/IV)USP Type I Glass Ampoule x 1mL (Box of 10's)
Rx
MERCURY LABORATORIES LTD.India
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-8202-01
Nov 17, 2028
GentoxynOxytocin
10 IU /mL Solution for Injection (IM/IV)USP Type I Glass Ampoule x 1 mL Box of 10's
Rx
Mercury Laboratories Ltd.India
GA2 Pharmaceutical IncImporter: MEDINOVA PHARMACEUTICAL INC.
DRP-8202-02
Nov 17, 2028
GocynOxytocin
10 I.U./mL Solution for Injection (I.M./I.V.)1 mL Type I clear and colorlress glass ampoule in Clear PVC tray (Box of 10's)
Rx
Ma'anshan BBCA Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-8474-02
Apr 16, 2031
GoxitocinOxytocin
10 IU/mL Solution for Injection (I.M./I.V.)1 mL USP Type I Amber glass ampoule (Box of 5's)
Rx
Apoorv InternationalIndia
Applied Pharmaceuticl Distribution Inc.Importer: Ambica International Corporation
DRP-6317-05
Jan 12, 2028
Goxy InjOxytocin
10 IU/mL Solution for Injection (I.M/I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-4985-06
Dec 11, 2028
GreatocynOxytocin
10 I.U./mL Solution for I.V. Injection (I.M./I.V. Infusion)USP Type I glass ampoule x 1 mL (net content) (Box of 10's)
Rx
Furen Pharmaceutical Group Co., Ltd.China
Asianmeds, Inc.Importer: Euro-Care Products Philippines
DRP-10762-01
Nov 16, 2031
Gyne-TocinOxytocin
10 IU/mL Solution for Injection (IM/IV)USP Type 1 Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Harmann Pharmaceutical Laboratories (Pvt) Ltd.Pakistan
Raquel-Abbas Pharmaceuticals & General Merchandise
DRP-9991
Apr 21, 2031
ImfetusOxytocin
10 I.U./mL Solution for Injection (I.V.)USP Type I Clear and Colorless Glass Ampoule x 1 mL in a Plastic Tray (Box of 10's)
Rx
Sterile-Gene Life Sciences (P) Ltd.India
Vamsler Phils. Inc.Importer: Lloyd Laboratories, Inc.
DR-XY47521
Dec 9, 2026
LavoxinOxytocin
10 IU / mL Solution for Injection (IM/IV Infusion)Type I Hydrolytic Resistant Glass Colourless Borosilicate Glass Ampoule x 1 mL (Net Content) (Box of 10’s)
Rx
HBM Pharma S.R.O.Slovak Republic
Scheeling, Inc.Importer: Ambica International CorporationTrader: JSC Grindeks
DRP-8748-01
Feb 21, 2030
LavoxinOxytocin
10 IU/mL Solution for Injection1 mL USP Type I Amber Glass Ampoule (Box of 5's)
Rx
Sanjivani Paranteral Ltd.India
Scheeling, Inc.Importer: Ambica International CorporationTrader: Unicare Healthsciences Pvt. Ltd.
DRP-6317-01
Jan 12, 2028
NoneOxytocin
10 IU/mL Solution for Injection (I.M/I.V./S.C.)1 mL USP Type I Clear Glass Ampoule x 1’s (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
Excelcare, IncImporter: Suhitas Pharmaceuticals Inc.
DRP-4985-02
Dec 11, 2028
NoneOxytocin
10 IU/mL Solution for Injection (IM/IV)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Maanshan BBCA Pharmaceutical Co., Ltd.China
Endure Medical Inc.
DR-XY44219
Feb 26, 2030
ObcinOxytocin
10 I.U./mL Solution for Injection (I.M./I.V.)Type I Clear Glass Ampoule in 1 mL (net content) (Box of 10's and 100’s)
Rx
PT. Sanbe Farma (Unit 3)Indonesia
Phoenix Pharmaceutical, Inc.
DR-XY46164
Nov 22, 2027
OcitoxinOxytocin
10 IU/mL Solution for Injection1 mL USP Type I Amber glass ampoule (Box of 5's)
Rx
Sanjivani Paranteral Ltd.India
Virrod Inc.Importer: Ambica International CorporationTrader: Unicare Healthsciences Pvt. Ltd.
DRP-6317-03
Jan 12, 2028
OratocinOxytocin
10 IU/mL Solution for Injection (I.M./I.V./S.C)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-4985-09
Dec 11, 2028
Oxitin-10Oxytocin
10 IU/mL Solution for Injection1 mL USP Type I Amber glass ampoule (Box of 5's)
Rx
Sanjivani Paranteral Ltd.India
Ambica International CorporationTrader: Unicare Healthsciences Pvt. Ltd.
DRP-6317
Jan 12, 2028
OxitoneOxytocin
10 I.U./mL Solution for Injection (I.M./I.V.)1 mL clear ampoule (Box of 25's)
Rx
Harson LaboratoriesIndia
Phil. Pharmawealth, Inc.
DRP-3114
Sep 4, 2027
OxtimonOxytocin
10 I.U. /mL Solution for InjectionType I Clear Colorless Glass Ampoule x 1 mL (Box of 10's)
Rx
Panpharma GmbHGermany
Duopharma Trade Phils., Inc.
DRP-464
Dec 7, 2030
OxtolevOxytocin
10 IU/mL Solution for Injection (I.M/I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-4985-05
Dec 11, 2028
OxycareOxytocin
10 I.U./mL Solution for I.V. Injection (I.M./I.V. Infusion)USP Type I glass ampoule x 1 mL (net content) (Box of 10's)
Rx
Furen Pharmaceutical Group Co., Ltd.China
Euro-Care Products Philippines
DRP-10762
Nov 16, 2031
OxycinOxytocin
10 IU/mL Solution for Injection (IM/IV Infusion)Type I glass vial x 1 mL (net content) with grey bromobutyl rubber stopper, aluminum seal, and blue flip-off cap (Box of 10's)
Rx
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd.China
Luoxin Pharmaceuticals (PH) Corp.
DR-XY49450
Jul 15, 2030
OxycoreOxytocin
10 I.U./mL Solution for Injection (I.V./I.M./S.C.)1 mL-net content USP Type I clear and colorless glass ampoule (Box of 10's)
Rx
Furen Pharmaceutical Group Co., Ltd.China
Greencore Pharma, Inc.
DRP-14663
Nov 17, 2028
OxyfarOxytocin
10 IU/mL Solution for Injection (IV)2 mL USP Type I Clear Glass Vial (Box of 1's)
Rx
Scott-Edil Pharmacia LimitedIndia
PHARMAKON BIOTEC INC.
DRP-7402
Oct 12, 2027
OxylaOxytocin
10 I.U./ mL Solution for Injection (I.M. / I.V.)Type I (Borosilicate) Clear Glass Ampoule in 1ml (net content) (Box of 10 ampoules)
Rx
PT. Novell Pharmaceutical LaboratoriesIndonesia
Prosweal Healthcare Inc.
DR-XY45566
Aug 19, 2031
Oxyt 10Oxytocin
10 IU/mL Solution for Injection (IM/IV)Type I Clear Glass Ampoule x 1 mL in White Opaque High Impact Polystyrene (HIPS) Tray (Box of 10's)
Rx
Steril-Gene Life Sciences (P) Ltd.India
Synergen Pharma Inc.Trader: Synergen Asia Pte. Ltd.
DR-XY47841
Mar 30, 2029
Oxyt 5Oxytocin
5 IU/mL Solution for Injection (IM/IV)Type I Clear Glass Ampoule x 1 mL in White Opaque HIPS Tray (Box of 10's)
Rx
Steril-Gene Life Sciences (P) Ltd.India
Synergen Pharma IncTrader: Synergen Asia Pte. Ltd.
DR-XY47842
Mar 30, 2029
OxytocyOxytocin
10 I.U. / mL Solution for Injection (I.M./I.V.)1 mL Type I Clear and Colorless Glass Ampoule in Clear PVC Tray (Box of 10's)
Rx
Ma'anshan BBCA Pharmaceutical Co., Ltd.P.R. of China
Cyden Medicale Trading Inc.Importer: AMB HK Enterprises Inc.
DRP-8474-05
Mar 18, 2031
OxytovinOxytocin
10 IU/mL Solution for Injection (I.M./I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
MDB Pharma TradingImporter: Suhitas Pharmaceuticals Inc.
DRP-4985-10
Dec 11, 2028
PopicinOxytocin
10 IU/mL Solution for Injection (I.M/I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-4985
Dec 11, 2028
RifoxynOxytocin
10 IU/mL Solution for Injection (I.M./I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Umedica Laboratories Pvt. Ltd.India
Rifemedica CorporationImporter: Suhitas Pharmaceuticals Inc.
DRP-4985-07
Dec 11, 2028
RoxipanOxytocin
10 I.U Solution for Injection (IM/IV)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Rotexmedica GmbHGermany
Panpharma Healthcare and Pharmaceuticals Inc.
DR-XY32916
Jan 31, 2027
SoloxineOxytocin
10 IU/mL Solution for Injection (I.M/I.V./S.C.)USP Type I Clear Glass Ampoule x 1 mL (Box of 10’s)
Rx
Umedica Laboratories Pvt. Ltd.India
Innogen Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-4985-01
Dec 11, 2028
SyntocinonOxytocin
10 I.U./mL Solution for Injection (I.M./I.V. Infusion)Type I colorless glass ampoule x 1 mL in PVC tray (Box of 10's)
Rx
Sovereign Pharma Private LimitedIndia
Viatris Pharmaceuticals, Inc.
DRP-1981
Sep 27, 2029
SyntomaxOxytocin
10 IU/mL Solution For Injection (IM/IV)1 mL clear Type I glass ampoule (Box of 50's and 10's)
Rx
Indus Pharma (Pvt.) Ltd.Pakistan
One Dexcel Pharma Inc
DRP-13669
Mar 23, 2028
SyntomaxOxytocin
5 IU per mL Concentrate for Solution for Injection (IV)1 mL USP Type I Clear Glass Ampoule (Box of 50's)
Rx
Indus Pharma (Pvt.) Ltd.Pakistan
One Dexcel Pharma Inc.
DRP-11844
May 6, 2027
TocinoxOxytocin
10 IU per mL Solution for Injection (IM/IV)Clear Glass Ampoule x 1 mL (Box of 1 Blister pack x 10's)
Rx
GEOFMAN PHARMACEUTICALSPakistan
SAHAR INTERNATIONAL TRADING INC.
DRP-973
Sep 27, 2027
UtexynOxytocin
10 IU/mL Solution for Injection (IM/IV)USP Type I Clear Glass Ampoule x 1 mL (Box of 10's)
Rx
Gland Pharma LimitedIndia
Importer: Endure Medical, Inc.
DR-XY43010
Nov 21, 2028
XetocinOxytocin
10 IU / mL Solution for Injection (I.M./I.V.)1 mL clear Type I glass ampoule (Box of 50's and 10's)
Rx
Indus Pharma (Pvt.) Ltd.Pakistan
Ellebasy Medicale Group Inc.Importer: One Dexcel Pharma Inc.
DRP-13669-01
Mar 23, 2028
XyntocOxytocin
10 IU /mL Solution for Injection (IM/IV)USP Type I Glass Ampoule x 1 mL (Box of 10's)
Rx
Mercury Laboratories Ltd.India
Medinova Pharmaceutical Inc.
DRP-8202
Nov 17, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS Oxytocin injection (synthetic) when given for induction or stimulation of labor, must be administered only by the intravenous route and with adequate medical supervision in a hospital.

Adverse reactions

Adverse reactions (US label) US FDA label

ADVERSE REACTIONS To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. The following adverse reactions have been reported in the mother:

  • Anaphylactic reaction
  • Postpartum hemorrhage
  • Cardiac arrhythmia
  • Fatal afibrinogenemia
  • Nausea
  • Vomiting
  • Premature ventricular contractions
  • Pelvic hematoma Excessive dosage or hypersensitivity to the drug may result in uterine hypertonicity, spasm, tetanic contraction or rupture of the uterus. The possibility of increased blood loss and afibrinogenemia should be kept in mind when administering the drug. Severe water intoxication with convulsions and coma has occurred, and is associated with a slow oxytocin infusion over a 24-hour period. Maternal death due to oxytocin-induced water intoxication has been reported. The following adverse reactions have been reported in the fetus or infant: Due to induced uterine mobility:
  • Bradycardia
  • Premature ventricular contractions and other arrhythmias
  • Permanent CNS or brain damage
  • Fetal death Due to use of oxytocin in the mother:
  • Neonatal retinal hemorrhage
  • Low Apgar scores at five minutes
  • Neonatal jaundice

Pharmacokinetics

Pharmacokinetics (US label) US FDA label

CLINICAL PHARMACOLOGY Oxytocin injection (synthetic) acts on the smooth muscle of the uterus to stimulate contractions; response depends on the uterine threshold of excitability. It exerts a selective action on the smooth musculature of the uterus, particularly toward the end of pregnancy, during labor and immediately following delivery.

Oxytocin stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions and raises the tone of the uterine musculature. Synthetic oxytocin does not possess the cardiovascular effects, such as elevation of blood pressure, as exhibited by vasopressin found in posterior pituitary injection.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Oxytocin 10 IU/mL, 1 mL Ampule₱4.93–₱44.98Reference ₱7.12per ampuleDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Oxytocin (synthetic)
PNF listingInj.: 10 IU/mL, 1 mL ampul (IM, IV)Restrictions: Limited indications or narrow spectrum of activity (PNF code 2)
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Oxytocin · Fresenius Kabi USA, LLC [US FDA-approved label, version 7, January 12, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7fd585a-99b7-4309-b003-a6cbef05372c
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .